Sekar Nishanth, Sundaresan K T
Internal Medicine, Teaching Hospital Batticaloa, Batticaloa, LKA.
Clinical Sciences, Eastern University of Sri Lanka, Batticaloa, LKA.
Cureus. 2022 May 14;14(5):e24986. doi: 10.7759/cureus.24986. eCollection 2022 May.
In a fast-evolving COVID-19 pandemic, co-infection with mucormycosis has been reported in some parts of the world. It is still unknown whether one of the either diseases makes the patient susceptible to developing the other. The co-occurrence of them significantly elevates the mortality risk and is commonly reported in immunocompromised individuals. We herein report a case of COVID-19 infection with rhinocerebral mucormycosis without prior steroid use or underlying immunosuppressive diseases.
在快速演变的新冠疫情中,世界上一些地区已报告了新冠病毒与毛霉菌病的合并感染情况。尚不清楚这两种疾病中的任何一种是否会使患者易患另一种疾病。它们的同时出现显著提高了死亡风险,并且在免疫功能低下的个体中很常见。我们在此报告一例新冠病毒感染合并鼻脑型毛霉菌病的病例,该患者此前未使用过类固醇,也没有潜在的免疫抑制疾病。